Evidence map›Paper›PMID 27667815›Full record

ArticleGlobal health action

Paragonimiasis in tuberculosis patients in Nagaland, India.

Mrinalini Das, Katerina Doleckova, Rahul Shenoy, Jagadish Mahanta, Kanwar Narain, K Rekha Devi, Tongmeth Konyak, Homa Mansoor, Petros Isaakidis

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Global health action. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Paragonimiasis.Advances in experimental medicine and biology · 2024
    Review
  3. Massive secretions in paragonimiasis pleural effusion: a new finding concerning clinical recognition and treatment.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  4. A curious case of hemoptysis.Medical journal, Armed Forces India · 2022
    Article
  5. An unusual presentation of pulmonary nodules.Medical journal, Armed Forces India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Mrinalini DasMédecins Sans Frontières (MSF), Delhi, India; msfocb-delhi-epi@brussels.msf.org.
Katerina DoleckovaMédecins Sans Frontières (MSF), Mon, Nagaland, India.
Rahul ShenoyMédecins Sans Frontières (MSF), Mon, Nagaland, India.
Jagadish MahantaRegional Medical Research Centre (RMRC), Dibrugarh, Assam, India.
Kanwar NarainRegional Medical Research Centre (RMRC), Dibrugarh, Assam, India.
K Rekha DeviRegional Medical Research Centre (RMRC), Dibrugarh, Assam, India.
Tongmeth KonyakMédecins Sans Frontières (MSF), Mon, Nagaland, India.
Homa MansoorMédecins Sans Frontières (MSF), Delhi, India.
Petros IsaakidisMédecins Sans Frontières (MSF), Delhi, India.
Regional Medical Research Centre · INMédecins Sans Frontières · LU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOne of the infections that mimic tuberculosis (TB) is paragonimiasis (PRG), a foodborne parasitic disease caused by lung flukes of the genus

objectiveTo address limited evidence on the dual burden of TB and PRG in northeastern India, we aimed to document the prevalence of PRG among TB patients using sputum smear, stool examination for children <15 years and ELISA.

designA cross-sectional study of patients receiving TB treatment in the Médecins Sans Frontières (MSF)-supported TB programme in Mon district, in collaboration with the Regional Medical Research Centre (RMRC), Dibrugarh, Assam, between November 2012 and December 2013.

resultsOf 96 patients screened between November 2012 and December 2013, three (3%) had pulmonary PRG and were successfully treated with praziquantel.

conclusionsPRG should be considered in the TB diagnostic algorithms in PRG-TB dual burden areas. In case of TB-PRG co-infection, it is preferable to treat PRG first followed by anti-TB treatment a few days later.

Indexed as

lung flukenortheastoperational researchpraziquantelzoonotic infection

Identifiers

PMID27667815
PMCPMC5035771
OpenAlexW2522443784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.